Current Report Filing (8-k)
August 23 2022 - 5:17PM
Edgar (US Regulatory)
0001538217
false
0001538217
2022-08-23
2022-08-23
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) August 23, 2022 (August 17, 2022)
SRAX,
INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-37916 |
|
45-2925231 |
(State
or other jurisdiction
of
incorporation or organization) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
No.) |
2629
Townsgate Road #215, Westlake Village, CA |
|
91361 |
(Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: |
|
(323)
694-9800 |
not
applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title
of Class |
|
Trading
Symbol |
|
Name
of Each Exchange on Which Registered |
Class
A Common stock |
|
SRAX |
|
NASDAQ
Global Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing rule or Standard; Transfer of Listing.
As
previously disclosed in the current reports on Form 8-K, filed by SRAX, Inc. (the “Company”) on April 27, 2022
and on July 7, 2022, the Listing Qualifications Department of the Nasdaq Stock Market, LLC
(“Nasdaq”) notified the Company that it did not comply with Nasdaq Listing Rule 5250(c)(1) because it had not yet filed its
Annual Report on Form 10-K for the year ended December 31, 2021 (the “2021 Form 10-K”) and Form 10-Q for the quarter ended
March 31, 2022 (the “2022 Q1 10-Q”) with the Securities and Exchange Commission (“SEC”).
On
August 17, 2022, the Company received an additional notice regarding Nasdaq Listing Rule 5250(c)(1) because it had not yet filed its
Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 (the “2022 Q2 10-Q”). Nasdaq Listing Rule 5250(c)(1) requires
listed companies to timely file all required periodic financial reports with the SEC.
Nasdaq
previously provided the Company with an extension of one hundred eighty (180) days from the initial due date of the 2021 Form 10-K or
until October 12, 2022, to regain compliance with Nasdaq’s continued listing rule as it relates to all of the untimely filings.
Accordingly, the Company’s (i) 2021 Form 10-K, (ii) 2022 Q1 10-Q, and (iii) 2022 Q2 10-Q are all required to be filed with the
SEC by October 12, 2022.
Additionally,
as a result of the additional late filing, Nasdaq requires the Company to update its original plan to regain compliance previously disclosed
to Nasdaq, including the progress that the Company has made in implementing its previously submitted plan in connection with the untimely
filings.
Item
8.01. Other Events.
On
August 22, 2022, the Company issued a press release announcing its receipt of the delisting notice from Nasdaq. A copy of the press release
is attached hereto as Exhibit 99.01 and is incorporated herein by reference.
Cautionary
Statement Regarding Forward Looking Statements
This
communication contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of
1995, including, without limitation, statements related to the anticipated filing of the 2021 Form 10-K, and other statements that are
not historical facts. Any statements contained in this communication that are not statements of historical fact may be deemed to be forward-looking
statements. Forward-looking statements may be identified by the use of words referencing future events or circumstances such as “expect,”
“intend,” “plan,” “anticipate,” “believe,” “will,” and similar expressions
and their variants. These forward-looking statements are based upon the Company’s current expectations. Forward-looking statements
involve risks and uncertainties. The Company’s actual results and the timing of events could differ materially from those anticipated
in such forward-looking statements as a result of these risks and uncertainties.
Item
9.01 Financial Statements and Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its
behalf by the undersigned hereunto duly authorized.
Date: |
August
23, 2022 |
SRAX,
Inc. |
|
|
|
|
|
/s/
Christopher Miglino |
|
|
By: |
Christopher
Miglino |
|
|
|
Chief
Executive Officer |
INDEX
OF EXHIBITS
SRAX (NASDAQ:SRAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SRAX (NASDAQ:SRAX)
Historical Stock Chart
From Apr 2023 to Apr 2024